• Issue

    The Prostate: Volume 81, Issue 10

    613-709
    July 1, 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 613
  • First Published: 25 May 2021

EDITORIAL

The end of “very low risk” in localized prostate cancer?

Federico Ferraris MD,  Fabian Yaber MD, PhD,  Angela B. Smith MD, MS, FACS,  Diego Barreiro MD, 
  • Pages: 615-617
  • First Published: 19 May 2021

ORIGINAL ARTICLES

The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer

Jen-Tsan Chi MD, PhD,  Pao-Hwa Lin PhD,  Vladimir Tolstikov PhD,  Taofik Oyekunle MS,  Gloria C. Galvan PhD,  Adela Ramirez-Torres PhD,  Emily Y. Chen BS,  Valerie Bussberg BS,  Bo Chi,  Bennett Greenwood MS,  Rangaprasad Sarangarajan B Pharm, PhD,  Niven R. Narain PhD,  Michael A. Kiebish PhD,  Stephen J. Freedland MD, 
  • Pages: 618-628
  • First Published: 05 May 2021
Open Access

Characterization of tumor-associated macrophages in prostate cancer transgenic mouse models

Amber E. de Groot PhD,  Kayla V. Myers,  Timothy E. G. Krueger,  Ashley L. Kiemen,  Natalia H. Nagy,  Alexandria Brame,  Vicente E. Torres,  Zhongyuan Zhang,  Levent Trabzonlu MD,  W. Nathaniel Brennen PhD,  Denis Wirtz PhD,  Angelo M. De Marzo MD, PhD,  Sarah R. Amend PhD,  Kenneth J. Pienta MD, 
  • Pages: 629-647
  • First Published: 05 May 2021

Clinical parameters and nomograms for predicting lymph node metastasis detected with 68Ga-PSMA-PET/CT in prostate cancer patients candidate to definitive radiotherapy

Cem Onal MD,  Gokhan Ozyigit MD,  Ezgi Oymak MD,  Ozan Cem Guler MD,  Pervin Hurmuz MD,  Burak Tilki MD,  Mehmet Reyhan MD,  Murat Tuncel MD,  Fadil Akyol MD, 
  • Pages: 648-656
  • First Published: 05 May 2021
Open Access

Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settings

Oliver Sartor MD,  Sreevalsa Appukkuttan MPH, MBBS,  Jeffrey Weiss BA,  Che-Kai Tsao MD, 
  • Pages: 657-666
  • First Published: 12 May 2021

Inverse agonism at the Na/K-ATPase receptor reverses EMT in prostate cancer cells

Moumita Banerjee,  Zhichuan Li,  Yingnyu Gao,  Fangfang Lai,  Minqi Huang,  Zhongbing Zhang,  Liquan Cai,  Juan Sanabria,  Tianyan Gao,  Zijian Xie,  Sandrine V. Pierre, 
  • Pages: 667-682
  • First Published: 06 May 2021

A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer

Victoria Wang PhD,  Milan S. Geybels PhD,  Kristina M. Jordahl MS, PhD,  Travis Gerke ScD,  Anis Hamid MBBS,  Kathryn L. Penney MPH, ScD,  Sarah C. Markt MPH, ScD,  Matthew Freedman MD,  Mark Pomerantz MD,  Gwo-Shu M. Lee PhD,  Huma Rana MPH, MD,  Daniela Börnigen PhD,  Timothy R. Rebbeck PhD,  Curtis Huttenhower PhD,  Ros A. Eeles FMedSci, PhD,  Janet L. Stanford MPH, PhD,  Practical Consortium,  Sonja I. Berndt Pharm D, PhD,  Frank Claessens PhD,  Karina D. Sørensen PhD,  Jong Y. Park PhD,  Ana Vega PhD,  Nawaid Usmani MD,  Lorelei Mucci MPH, ScD,  Christopher J. Sweeney MBBS, 
  • Pages: 683-693
  • First Published: 06 May 2021

Identification of a five gene signature to predict time to biochemical recurrence after radical prostatectomy

John P. Corradi PhD,  Christine White Cumarasamy MD,  Ilene Staff PhD,  Joseph Tortora MS,  Andrew Salner MD,  Tara McLaughlin PhD,  Joseph Wagner MD, 
  • Pages: 694-702
  • First Published: 18 May 2021

RAPID COMMUNICATION

Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients

Jianfeng Xu MD, DrPH,  William B. Isaacs PhD,  Mufaddal Mamawala MBBS, MPH,  Zhuqing Shi PhD,  Patricia Landis BA,  Jacqueline Petkewicz MA,  Jun Wei PhD, MSE,  Chi-Hsiung Wang PhD,  W. Kyle Resurreccion BS,  Rong Na MD, MPH,  Yasin Bhanji MD,  Kristian Novakovic MD,  Patrick C. Walsh MD,  S. Lilly Zheng MD,  Brian T. Helfand MD, PhD,  Christian P. Pavlovich MD, 
  • Pages: 703-709
  • First Published: 06 May 2021